NasdaqGS - Delayed Quote USD
Embecta Corp. (EMBC)
At close: October 25 at 4:00 PM EDT
After hours: October 25 at 6:35 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 0.36 | 0.56 | 2.39 | 2.27 |
| Low Estimate | 0.3 | 0.47 | 2.32 | 2.03 |
| High Estimate | 0.59 | 0.63 | 2.61 | 2.48 |
| Year Ago EPS | 0.59 | 0.61 | 2.99 | 2.39 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | 276.99M | 277.25M | 1.11B | 1.12B |
| Low Estimate | 276M | 270.4M | 1.11B | 1.11B |
| High Estimate | 278.4M | 283M | 1.12B | 1.13B |
| Year Ago Sales | 281.9M | 264.91M | 1.12B | 1.11B |
| Sales Growth (year/est) | -1.70% | 4.70% | -0.60% | 0.50% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.4 | 0.45 | 0.4 | 0.46 |
| EPS Actual | 0.59 | 0.61 | 0.67 | 0.74 |
| Difference | 0.19 | 0.16 | 0.27 | 0.28 |
| Surprise % | 47.50% | 35.60% | 67.50% | 60.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.36 | 0.56 | 2.39 | 2.27 |
| 7 Days Ago | 0.36 | 0.56 | 2.39 | 2.27 |
| 30 Days Ago | 0.36 | 0.56 | 2.39 | 2.27 |
| 60 Days Ago | 0.36 | 0.57 | 2.39 | 2.29 |
| 90 Days Ago | 0.53 | 0.53 | 2.28 | 2.2 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EMBC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -39.00% | -- | -- | 4.50% |
| Next Qtr. | -8.20% | -- | -- | 9.60% |
| Current Year | -20.10% | -- | -- | 2.10% |
| Next Year | -5.00% | -- | -- | 12.90% |
| Next 5 Years (per annum) | -- | -- | -- | 11.76% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Underweight to Underweight | 7/15/2024 |
| Maintains | Morgan Stanley: Underweight to Underweight | 5/10/2024 |
| Maintains | Morgan Stanley: Underweight to Underweight | 11/22/2023 |
| Maintains | Morgan Stanley: Underweight to Underweight | 10/18/2023 |
| Maintains | Morgan Stanley: Underweight to Underweight | 8/24/2023 |
| Maintains | Morgan Stanley: Underweight to Underweight | 7/18/2023 |
Related Tickers
BDX Becton, Dickinson and Company
238.13
-0.21%
ANGO AngioDynamics, Inc.
6.73
-5.08%
HAE Haemonetics Corporation
75.56
-0.33%
COO The Cooper Companies, Inc.
107.82
+0.48%
UTMD Utah Medical Products, Inc.
64.12
-0.26%
TFX Teleflex Incorporated
233.63
-0.84%
XRAY DENTSPLY SIRONA Inc.
23.31
-4.51%
ALC Alcon Inc.
94.25
-0.15%
ATR AptarGroup, Inc.
168.91
+1.42%
BAX Baxter International Inc.
35.97
-2.07%